Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Current pneumococcal vaccines are composed of capsular polysaccharides (PS) of various serotypes, either as free PS or as protein-PS conjugates. The use of pneumococcus protein antigens that are able to afford protection across the majority of serotypes is envisaged as a relevant alternative and/or complement to the polysaccharides. In this context, based on several studies, the Pht protein family emerged as relevant vaccine candidates. The purpose of the present study was to evaluate the Pht protein family in several preclinical mouse models. Immunization with these antigens was compared with immunization with other pneumococcal antigens, such as CbpA, PspA, and PsaA. In a nasopharyngeal colonization model and in a lung colonization model, the Phts were found to be superior to the other candidates in terms of efficacy of protection and serotype coverage. Likewise, vaccination with PhtD allowed higher animal survival rates after lethal intranasal challenge. Finally, a passive transfer model in which natural anti-PhtD human antibodies were transferred into mice demonstrated significant protection against lethal intranasal challenge. This indicates that natural anti-PhtD human antibodies are able to protect against pneumococcal infection. Our findings, together with the serotype-independent occurrence of the Phts, designate this protein family as valid candidate antigens to be incorporated in protein-based pneumococcal vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dintilhac, A., Alloing, G., Granadel, C., & Claverys, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.5111879.x · Cited by 380
Berry, A. M., & Paton, J. C. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.5255-5262.1996 · Cited by 261 · cited 10×
“Examples include the cholesterol-binding cytotoxin pneumolysin (Ply) or its nontoxic genetically derived pneumolysin toxoid mutants (2, 17, 44); the choline-binding proteins PspA, CbpA (PspC), and PcPA (7, 10, 13, 20); the metalbinding lipoprotein PsaA (4, 15); the iron uptake ABC transporters PiuA and PiaA (8, 49); t…”
BackgroundInfluentialOgunniyi, A. D., Grabowicz, M., Mahdi, L. K., Cook, J., Gordon, D. L., Sadlon, T. A., & Paton, J. C. (2009) · The FASEB Journal · doi:10.1096/fj.08-119537 · Cited by 127
Rioux, S., Neyt, C., Di Paolo, E., Turpin, L., Charland, N., Labbé, S., Mortier, M.-C., Mitchell, T. J., Feron, C., Martin, D., et al. (2011) · Microbiology · doi:10.1099/mic.0.042184-0 · Cited by 75
Self-citation1.2 Å crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold
Riboldi-Tunnicliffe, A., Isaacs, N. W., & Mitchell, T. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.066 · Cited by 49
Cited by
Rioux, S., Neyt, C., Di Paolo, E., Turpin, L., Charland, N., Labbé, S., Mortier, M.-C., Mitchell, T. J., Feron, C., Martin, D., et al. (2011) · Microbiology · doi:10.1099/mic.0.042184-0 · Cited by 75
“The different members of the Pht family have already been evaluated for their potential as pneumococcal vaccine antigens (Adamou et al., 2001; Godfroid et al., 2011; Hamel et al., 2004; Ogunniyi et al., 2007; Wizemann et al., 2001; Zhang et al., 2001).”
BackgroundSelf-citationPolyhistidine triad proteins of pathogenic streptococci
Plumptre, C. D., Ogunniyi, A. D., & Paton, J. C. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.06.004 · Cited by 60
Loisel, E., Chimalapati, S., Bougault, C., Imberty, A., Gallet, B., Di Guilmi, A. M., Brown, J., Vernet, T., & Durmort, C. (2011) · Biochemistry · doi:10.1021/bi200012f · Cited by 50
Bersch, B., Bougault, C., Roux, L., Favier, A., Vernet, T., & Durmort, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081168 · Cited by 49
“pneumoniae [37,38,39] as well as across pneumococcal serotypes [40,41].”
Background
Metadata
- Authors
- Godfroid, F., Hermand, P., Verlant, V., Denoël, P., & Poolman, J. T.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2011-01
- Volume
- 79
- Issue
- 1
- Pages
- 238-245
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2159602930
- Cited by
- 99
- References
- 5
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens. https://app.cochat.ai/papers/10.1128/iai.00378-10
- The paper
- Godfroid, F., Hermand, P., Verlant, V., Denoël, P., & Poolman, J. T. (2011). Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens. Infection and Immunity. https://doi.org/10.1128/iai.00378-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.